Trial Details
RECRUITINGBasic Information
| Clinical ID | c989 |
|---|---|
| Identifier | NCT06290934 |
| Trial Title | Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: GS-1427|DRUG: Placebo-to-match GS-1427 |
Participant Information
| Sponsor | Gilead Sciences |
|---|---|
| City | Peoria |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-03-27 |
|---|---|
| Primary Completion Date | 2025-10-25 |
| Completion Date | 2025-02-27 |